✨ Free AI Report
AC Immune AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview AC Immune AG
Research Preview

AC Immune AG: Business Overview, Financials & Competitive Analysis

AC Immune is a Swiss-based biopharmaceutical company focused on developing immunotherapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary SupraAntigen and Morph...

Analyst-debate audio for AC Immune AG

AskCyborg analysts argue the bull and bear cases for AC Immune AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
AC Immune AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

AC Immune represents a focused play on neurodegeneration therapies with differentiated technology and strategic partnerships, but...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals - Neurodegenerative Diseases / Immunotherapy
3 named competitors
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest AC Immune AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

AC Immune AG Overview

Pro stress-test →

AC Immune is a Swiss-based biopharmaceutical company focused on developing immunotherapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary SupraAntigen and Morphomer technology platforms to develop disease-modifying treatments.

Strategic Profile

Pro stress-test →

AC Immune positions itself as a pioneer in neuroinflammation and tau-targeting therapeutics. The company operates through partnerships with major pharmaceutical firms and maintains a robust pipeline of clinical-stage candidates aimed at slowing or halting cognitive decline in Alzheimer's disease.

Competitive Landscape

Pro stress-test →

AC Immune competes with major biotech and pharma firms developing Alzheimer's treatments including Eli Lilly, Roche, Biogen, and Novartis. Its differentiation lies in its tau-targeting and immunotherapy approaches within a crowded neurodegeneration space.

Industry Context

AC Immune AG operates in Biopharmaceuticals - Neurodegenerative Diseases / Immunotherapy.

Key facts

Founded: 2003 · Headquarters: Zug, Switzerland

What the analysts stress-tested

The top findings that survived the multi-agent debate for AC Immune AG.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Lecanemab (Leqembi)Anti-amyloid monoclonal antibody for Alzheimer's→AducanumabPreviously approved Alzheimer's therapeutic→GLP-1 agonistsEmerging applications in neurodegenerative disease→

Compare AC Immune AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

AC Immune AG operates in Biopharmaceuticals - Neurodegenerative Diseases / Immunotherapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals - Neurodegenerative Diseases / Immunotherapy research →
NEW · MCP server

Ask your AI assistant about AC Immune AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare AC Immune AG and its top competitor on Cyborg Score”
“What did AC Immune AG do this quarter?”
“Is AC Immune AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does AC Immune AG do?+
AC Immune is a Swiss-based biopharmaceutical company focused on developing immunotherapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary SupraAntigen and Morph...
What is AC Immune AG's Cyborg Score?+
AC Immune AG has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are AC Immune AG's main competitors?+
Named competitors include Lecanemab (Leqembi), Aducanumab, GLP-1 agonists. The full competitive landscape is in the AskCyborg report.
How can I get the full AC Immune AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the AC Immune AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track AC Immune AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biopharmaceuticals - Neurodegenerative Diseases research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Acumen Pharmaceuticals, Inc.